Track record · closed signal

Gilead Sciences Inc (GILD) — closed signal from May 22, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 20, 2026.

Predicted vs. what happened

GILD price · publication thesis → realized outcomesplit-adjusted
$132.43 Published $149.98 Target $143.44 Window close $148.97 Peak
$126.33 – $132.75Entry zone — fair-value band
$132.43Published — price the day we called it
$149.98Target — the price the thesis aimed for
$148.97Peak — highest point inside the window, not a realized return
$143.44Window close — end-of-window price, context only

What happened

Target reached

Hit or exceeded the predicted growth inside the window.

Peak price
$148.97
peak on August 19, 2026 — not a realized return
Peak gain
+12.5%
peak, from the publication price
Window close
$143.44
end-of-window price, context only
Days to target
—
Window
May 22, 2026 – August 20, 2026

The thesis — published May 22, 2026

Predicted growth
+14%
over the measurement window
Target price
$149.98
the price the thesis aimed for
Entry zone
$126.33 – $132.75
the fair-value band we waited for
Price at publication
$132.43
published May 22, 2026
Confidence
78%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Gilead offers a defensive health-care holding backed by clear drug news instead of broad market moves. A positive regulatory opinion for Trodelvy plus upcoming oncology and cell-therapy trial updates could renew interest. Strong profit margins and repeated earnings beats help balance concerns about debt and insider selling, and recent heavy buying supports a short-term rebound case.

Primary drivers

  • Trodelvy regulatory nod boosts oncology momentum
  • Upcoming ASCO and EHA data could drive clinical news
  • High margins and repeated earnings beats show profitability
  • Lower sensitivity to the market adds defensive balance

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All GILD signals